SCHEMBL20095534

SCHEMBL20095534

COc1ccc(CN(Sc2cc(Cl)c(N)cc2F)c2nccs2)c(OC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
KDM4E B2RXH2 2/20 0.33
DHFR P00374 1/20 0.33
TSHR P16473 4/20 0.33
GAA P10253 2/20 0.33
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C19 P33261 3/20 0.32
ALDH1A1 P00352 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634090 0.92 HTR2A (0.38) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL19634093 0.84 MEN1 (0.36) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL19001206 0.84 MEN1 (0.36) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL20256208 0.84 MEN1 (0.37) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL20256546 0.84 KDM4E (0.36) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL20095558 0.83 GAA (0.41) SLC6A4MEN1KMT2ASCN1ASCN2A
SCHEMBL20256130 0.83 CYP1A2 (0.37) MEN1KMT2ASCN1AKDM4ETSHR
SCHEMBL20256424 0.83 SCN1A (0.36) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL20256699 0.83 KDM4E (0.38) HTR2ASLC6A4KCNH2MEN1KMT2A
SCHEMBL20256524 0.83 KDM4E (0.36) MEN1KMT2ASCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 WO disclosed
US-9242974-B2 Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives ENANTA PHARMACEUTICALS, INC. (US) 2016-01-26 US disclosed